Camilleri M. Diagnosis and Treatment of Irritable Bowel Syndrome. A Review. JAMA 2021;325(9):865.
Chlebicz-WÃ³jcik, A. et al. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review. Biomolecules 2021;11:1154.
Ford AC et al. Functional dyspepsia. Lancet 2020;396:1689. Shiha MG et al. Review article: Physical and psychological comorbidities associated with irritable bowel syndrome. Alim Pharmacol Ther 2021;54(Suppl. 1):S12.
Hanning N et al. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic reviewTher Adv Gastroenterol 2021,14:1.
Chapelle N et al. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD). Expert Opin Pharmacother 2021;22:219.
Tsai K et al. Subclinical Hyperthyroidism: A Review of the Clinical Literature.Endocr Pract 2021;27:254. Hughes K et al. Thyroid disease: Long-term management of hyperthyroidism and hypothyroidism. Aust J Gen Pract 2021;50:36.
Seidu S et al. 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care. Prim Care Diabetes 2022:S1751-9918(22)00031-6.
